Literature DB >> 25047693

The medico-legal aspects of prescribing vitamin D.

John S Davies1, Chris D Poole, Peter Feldschreiber.   

Abstract

Vitamin D is a particularly important sterol hormone and its effects beyond bone are increasingly recognized. Over the last decade clinical interest has grown in vitamin D, with increased recognition of deficiency and hence increased prescribing of vitamin D products. However, the increased prescription of vitamin D has generally been met with unlicensed vitamin D products which potentially expose the patient to clinical risk. This review discusses the issues relating to the clinical use of unlicensed vitamin D products, safety concerns that may arise from this, as well as discussing the medico-legal responsibilities of the prescriber and dispenser.
© 2014 The British Pharmacological Society.

Entities:  

Keywords:  colecalciferol; prescription; unlicensed; vitamin D

Mesh:

Substances:

Year:  2014        PMID: 25047693      PMCID: PMC4256615          DOI: 10.1111/bcp.12472

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  20 in total

1.  Vitamin D intoxication associated with an over-the-counter supplement.

Authors:  P Koutkia; T C Chen; M F Holick
Journal:  N Engl J Med       Date:  2001-07-05       Impact factor: 91.245

2.  Dietary supplement-induced vitamin D intoxication.

Authors:  Karl C Klontz; David W Acheson
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

3.  It's time for new rules on vitamin D food supplements.

Authors:  Silvia Benemei; Eugenia Gallo; Elisa Giocaliere; Gianluca Bartolucci; Francesca Menniti-Ippolito; Fabio Firenzuoli; Alessandro Mugelli; Alfredo Vannacci
Journal:  Br J Clin Pharmacol       Date:  2013-11       Impact factor: 4.335

4.  Vitamin D toxicity due to a commonly available "over the counter" remedy from the Dominican Republic.

Authors:  Hyesoo Lowe; Natalie E Cusano; Neil Binkley; William S Blaner; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2010-12-01       Impact factor: 5.958

5.  Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study.

Authors:  S Turner; A J Nunn; K Fielding; I Choonara
Journal:  Acta Paediatr       Date:  1999-09       Impact factor: 2.299

6.  Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study.

Authors:  Ben Schöttker; Ulrike Haug; Lutz Schomburg; Joseph Köhrle; Laura Perna; Heiko Müller; Bernd Holleczek; Hermann Brenner
Journal:  Am J Clin Nutr       Date:  2013-02-27       Impact factor: 7.045

7.  Vitamin D intoxication due to an erroneously manufactured dietary supplement in seven children.

Authors:  Cengiz Kara; Figen Gunindi; Ala Ustyol; Murat Aydin
Journal:  Pediatrics       Date:  2013-12-02       Impact factor: 7.124

8.  Adverse drug reactions in a paediatric intensive care unit.

Authors:  A M Gill; H J Leach; J Hughes; C Barker; A J Nunn; I Choonara
Journal:  Acta Paediatr       Date:  1995-04       Impact factor: 2.299

9.  Vitamin D deficiency induces early signs of aging in human bone, increasing the risk of fracture.

Authors:  Björn Busse; Hrishikesh A Bale; Elizabeth A Zimmermann; Brian Panganiban; Holly D Barth; Alessandra Carriero; Eik Vettorazzi; Josef Zustin; Michael Hahn; Joel W Ager; Klaus Püschel; Michael Amling; Robert O Ritchie
Journal:  Sci Transl Med       Date:  2013-07-10       Impact factor: 17.956

Review 10.  Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials.

Authors:  H A Bischoff-Ferrari; B Dawson-Hughes; H B Staehelin; J E Orav; A E Stuck; R Theiler; J B Wong; A Egli; D P Kiel; J Henschkowski
Journal:  BMJ       Date:  2009-10-01
View more
  3 in total

1.  Commentary on the medico-legal aspects of prescribing vitamin D.

Authors:  Scott Downham; Christopher Holt; Frances Dockery; Andrew J Webb
Journal:  Br J Clin Pharmacol       Date:  2015-06-24       Impact factor: 4.335

2.  Re: The medico-legal aspects of prescribing vitamin D.

Authors:  Helga Rhein
Journal:  Br J Clin Pharmacol       Date:  2015-06-24       Impact factor: 4.335

Review 3.  A review of the growing risk of vitamin D toxicity from inappropriate practice.

Authors:  Peter N Taylor; J Stephen Davies
Journal:  Br J Clin Pharmacol       Date:  2018-04-16       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.